Press Release

Antitussive Drugs Market to Grow with a CAGR of 5.25% through 2028

Increasing Prevalence of Respiratory Diseases and Infections and increase in the aging population is expected to drive the Global Antitussive Drugs Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Antitussive Drugs Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Antitussive Drugs Market stood at USD 1.45 billion in 2022 and is anticipated to grow with a CAGR of 5.25% in the forecast period, 2024-2028. The awareness among individuals regarding Antitussive Drugs has led to favorable market conditions for the global Antitussive Drugs market. Several factors contribute to the growth of various Antitussive Drugs products.

The global antitussive drugs market is experiencing increased demand due to the rising burden of respiratory diseases. Factors such as air pollution, smoking habits, and aging populations have contributed to this trend. One of the primary catalysts driving the growth of this market is the prevalence of respiratory diseases and infections. Conditions like asthma, chronic obstructive pulmonary disease (COPD), bronchitis, and pneumonia frequently result in persistent and distressing coughing episodes. In response to these symptoms, healthcare providers often prescribe antitussive drugs to effectively manage coughing and enhance the overall quality of life for patients.

           

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Antitussive Drugs Market.”

 

The worsening air quality in many cities around the world has led to an increased prevalence of respiratory symptoms and diseases, thereby boosting the demand for antitussive drugs as a means to alleviate coughing associated with pollution-related health issues, which will further fuel market growth.

In September 2023, Teva will present data for AUSTEDO® XR (deutetrabenazine) extended-release tablets, AUSTEDO® (deutetrabenazine) capsules, and AUSTEDO® (deutetrabenazine) oral solution at the 34th European College of Neuropsychopharmacology (ECNP) Congress. The data will highlight the efficacy, safety, and tolerability of AUSTEDO® in patients with Huntington's disease and tardive dyskinesia.

Improved access to healthcare facilities, including pharmacies and over-the-counter (OTC) products, also contributes to the growth of the antitussive drugs market. Consumers can readily purchase cough suppressants, making these medications more accessible and convenient.

In today's fast-paced world, In a world where time is of the essence, constant coughing can be not only physically uncomfortable but also socially disruptive. Antitussive drugs help individuals manage coughing symptoms efficiently, allowing them to focus on their tasks without the distraction of persistent coughing. For professionals and workers in various industries, an uninterrupted workflow is crucial. Coughing fits can disrupt concentration, meetings, and deadlines. Antitussive medications enable individuals to maintain their productivity levels by minimizing or eliminating disruptive coughing spells. In our fast-paced world, restorative sleep is essential for mental alertness and physical well-being. Coughing can disrupt sleep patterns, leading to fatigue and decreased productivity during the day. Antitussive drugs can provide uninterrupted sleep, ensuring individuals wake up refreshed and ready to face their daily challenges. Effective communication is vital in both personal and professional settings. Chronic coughing can hinder clear and productive communication. Antitussive medications help individuals communicate more effectively, whether in business meetings, social gatherings, or everyday conversations. In social situations, persistent coughing can lead to embarrassment and social discomfort. Antitussive drugs offer relief from coughing, enabling individuals to participate in social events and interactions with confidence.

The convenience of antitussive drugs, available in various formulations like tablets, syrups, and lozenges, allows individuals to choose the most suitable option for their lifestyle and preferences. This convenience aligns with the fast-paced nature of modern life.

In recent times, Antitussive drugs are commonly prescribed to individuals with respiratory infections, including the flu and common cold. These medications help alleviate coughing, making patients more comfortable during the course of the illness. Patients with chronic respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and bronchitis often experience persistent coughing. Antitussive drugs are used as part of the treatment regimen to manage this troublesome symptom. Allergic reactions to environmental allergens or irritants can lead to coughing fits. Antitussive medications help reduce coughing episodes, providing relief to individuals with allergies. After surgical procedures, coughing can strain incisions and sutures. Antitussive drugs may be prescribed to post-operative patients to minimize coughing and support the healing process. However, the Regulatory Hurdles and Stringent Approvals may hinder market growth. Moreover, challenges related to Increasing Competition and Generic Substitution and Evolving Healthcare Trends may pose obstacles to the Antitussive Drugs market in the near future.

The Global Antitussive Drugs Market is segmented into Drug class, route of administration, age group, end-user, regional distribution, and company.

Based on its drug class, the Peripherally acting drugs have become dominant in the global antitussive drug market due to several factors that enhance their effectiveness, safety, and market appeal. Peripherally acting antitussive drugs primarily target the cough reflex at the level of the peripheral nervous system or the respiratory tract. Peripherally acting antitussive drugs typically do not exert their effects on the central nervous system (CNS) to the same extent as centrally acting drugs, particularly opioids. This reduced central nervous system penetration results in a lower risk of side effects like drowsiness, sedation, and dependence, making peripherally acting drugs a safer option for a broader patient population. Many peripherally acting antitussive drugs do not contain opioids, which have faced increasing scrutiny due to their potential for abuse and addiction. Non-opioid antitussive options align with evolving healthcare trends focused on minimizing opioid usage, especially in cases where alternatives are available.

Based on region, North America segment is expected to grow during the forecast period.  North America, including The United States and Canada has been a dominant region in the global antitussive drugs market. Reasons for dominance include a large population, a high prevalence of respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), and a well-developed healthcare infrastructure. The region's strong pharmaceutical industry, coupled with a high level of healthcare expenditure, has contributed to the prominence of North America in the market.

The Asia-Pacific market is poised to be the fastest-growing market, offering lucrative growth opportunities for Antitussive Drugs players during the forecast period. Factors such as The Asia-Pacific region is home to a significant portion of the world's population, including a growing elderly demographic. Aging populations are more susceptible to respiratory conditions, including chronic coughing, which drives the demand for antitussive medications. Rapid industrialization, urbanization, and environmental pollution have led to a rise in respiratory health concerns in many Asia-Pacific countries. Poor air quality, exacerbated by pollution, contributes to higher incidences of respiratory conditions and coughing, necessitating the use of antitussive drugs. Improvements in healthcare access and awareness in the Asia-Pacific region have led to earlier diagnosis and treatment of respiratory conditions. Patients and healthcare providers have become more aware of the importance of managing coughing and related symptoms, driving the demand for antitussive drugs.

 

Major companies operating in Global Antitussive Drugs Market are:

  • Teva Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Bayer AG
  • Ipca Laboratories Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Hikma Pharmaceuticals PLC
  • Unique Pharmaceuticals Limited
  • Cipla Inc.
  • Mylan N.V.
  • Aurobindo Pharma

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The Consumer Awareness and Accessibility and increasing pollution level are key drivers of the Antitussive Drugs market. In recent years, Growing awareness of respiratory health issues and the availability of antitussive drugs, including over-the-counter options, influence market demand. Ongoing research and development efforts lead to the introduction of new antitussive medications, expanding the market. Moreover, the growing consumer emphasis on preventative healthcare products has enhanced production and marketing efforts. To meet the demands of the market, manufacturers are increasingly incorporating cutting-edge technologies with high production efficiency. Rising consumer acceptance and continuous product innovation will further ensure the growth of the Antitussive Drugs and supplements market in the coming years.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Antitussive Drugs Market – Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028 Segmented By Drug Class (Peripherally Acting Drugs, Centrally Acting Drugs, Others), By Route of Administration (Inhalational, Oral, Others), By Age Group (Geriatric, Pediatric, Adult), By End-User (Homecare, Hospitals & Specialty Clinics, Others), By Region, Competition”, has evaluated the future growth potential of Global Antitussive Drugs Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Antitussive Drugs Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com

Relevant News